At AACC booth 1015, DiaSorin will feature its 1,25 dihydroxyvitamin D assay, available on the Liaison XL analyzer. The assay is the first commercially available extraction-free, fully automated 1,25 dihydroxyvitamin D assay. Traditional 1,25 dihydroxyvitamin D assays require a time-consuming, up-front extraction step. DiaSorin’s new assay eliminates the extraction step, providing higher throughput and a faster time-to-first-result of 65 minutes.

 Correction 
A version of this story transmitted on July 1, 2015, erroneously referred to DiaSorin’s chemiluminescent immunoassay for 1,25 dihydroxyvitamin D as a “CLIA-waived” test. It is actually categorized as moderately complex. The editors regret the error. 
The chemiluminescent immunoassay quantitatively determines 1,25 dihydroxyvitamin D in ethylenediaminetetraacetic acid plasma, lithium heparin plasma, and serum. It enables laboratories with Liaison XL analyzers to run the company’s 25 OH vitamin D Total assay, N-TACT parathyroid hormone Gen II assay, and 1,25 dihydroxyvitamin D assay together on one instrument utilizing a single serum sample tube. For more information, visit DiaSorin.